MaxCyte (MXCT) Q2 2026 earnings call recap: revenue beat, reiterated 2026 guidance, Genentech partnership, and H2 growth outlook—read key takeaways.
$MXCT
Price history, market instrument context, member research, and related headlines in one place.
MXCT key statistics
NasdaqGSUSD
52-week range
$0.64357%$1.81
Latest session $1.26–$1.31MaxCyte, Inc. (MXCT) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $1.30, up $0.05 (4.00%) from the previous close of $1.25. It has traded between $1.26 and $1.31 in the latest session. Over the past year it has ranged from $0.643 to $1.81, leaving it around the middle of its 52-week range (57%). Reported volume for the session was 3.8M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $MXCT research…